New discovery could make stem cells much more effective at repairing heart damage

Michael Walter | | Cardiovascular Business | Heart Failure
heart stem cell research lab
Image courtesy of UC Regents / UC Davis Health

Researchers have been attempting to repair damaged heart tissue with stem cells for years, but severe inflammation often makes it impossible for much change to actually occur. A new study published in Stem Cells Translational Medicine, however, suggests that a cardiologist-led team has identified a potential solution to this problem—one that could be a literal life-saver for heart failure patients.

The group identified an enzyme that has already been connected to inflammation in the lungs and joints—soluble epoxide hydrolase (sEH)—and was able to effectively block it from overwhelming the stem cells. Their experiments with mice have been a success—test subjects treated with an sEH inhibitor and human-induced pluripotent stem cells had the best outcomes—and it is possible that his work could help repair damage done to a patient’s heart following a myocardial infarction.  

“We think we’ve found a way to quiet that inflammatory environment, giving stem cells a chance to survive and do the healing work we know they can do,” lead author Padmini Sirish, PhD, division of cardiovascular medicine at the University of California, Davis, said in a statement.

Senior author Nipavan Chiamvimonvat, MD, a cardiologist at UC Davis who led the research team, noted in the same statement that she hopes to launch human clinical trials based on her team’s findings.

“It is my dream as a clinician and scientist to take the problems I see in the clinic to the lab for solutions that benefit our patients,” she said.

The full analysis from Stem Cells Translational Medicine is available here.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 19 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Related Content

FDA approves Bayer's finerenone to treat wide range of heart failure patients
ASE shares new recommendations for evaluating LV diastolic function, HFpEF
World’s first patient receives new-look heart pump—cardiologist ‘impressed’ by device’s performance
FDA shares warning after Johnson & Johnson heart pump controllers linked to 3 deaths
Medtronic’s new ECMO system receives a key approval
Women less likely to receive DCD heart transplants

Around the web

Health Exec
Major association of physicians presents itself as a go-to alternative vs. the government on vaccine expertise

One of the most formidable societies of medical professionals in the U.S. is going toe-to-toe with Robert F. Kennedy’s HHS over changing vaccination recommendations. 

Health Exec
Tom Price: Medical residency slots need to expand to combat physician shortages

Tom Price, MD, former secretary of Health and Human Services (HHS), said one way to address the growing shortage of physicians is to expand medical resident positions, but these are tied to Medicare spending so alternative means may be needed.

Health Imaging
Tariffs will have a significant impact on the nuclear imaging supply chain in the US

"Domestic radiopharmaceutical suppliers, who receive isotopes from abroad, would be impacted by price changes and uncertainty caused by additional tariffs,” SNMMI President Cathy Cutler, PhD, wrote in a letter to the U.S. Department of Commerce this week.